What's breaking now, across thousands of outlets.
Researchers at the Center for Genomic Regulation (CRG) have developed a new way of identifying new druggable sites on a family of proteins that could help design treatments with fewer side effects for a very wide range of conditions from heart disease to depression.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors. Now, researchers at the University of Michigan Health Rogel Cancer Center are taking a new approach…
A newly proposed way of identifying obesity could flip the diagnoses of millions of people. Proponents argue it could lead to more precise care.
'An intelligent interface.' Don't miss a story, subscribe here.
Scientists have reconstructed how acute myeloid leukemia (AML) develops over the decades before diagnosis, showing that in two-thirds of cases the first cancer-driving mutation had been acquired…
A new diagnostic definition of obesity outperforms body mass index (BMI) in identifying differences in health and prognosis, including mortality risk, according to a large international study…
Combining body mass index with other measurements and tests would lead to better care and outcomes, experts say An alternative to BMI for diagnosing obesity could prevent misdiagnosis in millions of…
